albendazole sulfoxide
This page covers all albendazole sulfoxide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tubulin alpha chain, Mitogen-activated protein kinase 14, Beta-lactamase 1.
Targets
Tubulin alpha chain · Mitogen-activated protein kinase 14, Beta-lactamase 1
Marketed (3)
- Ricobendazole · Other
- Febendazole · Oncology
- Flumoxane · Other
Phase 2 pipeline (1)
- Dibazol · Cardiovascular
Dibazol works by interacting with a specific biological target to produce a therapeutic effect.
Patent intelligence
- bendazol patent landscape — aggregated cliff calendar, attackable patents, originator estates